Most Popular Reagents
Instruments
Antibodies
ELISA Kits
Protein Electrophoresis and Blotting
Protein and Antibody Purification
Recombinant Proteins
Molecular Biology
Stable Cell Lines
Cell Isolation and Activation
IVD Raw Materials
Therapy Applications
Resources
41+ off-the-shelf drug targets
Monoclonal and polyclonal, non-/blocking available
SPR+BLI verification Kd＜10-10M
{{ itemName }}
{{ category.name }}
{{ item.name }}
No Data
Anti-Abatacept/Orencia (Target: CTLA-4-Fc)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02262-40 | Anti-Abatacept Antibody (CT.F3), mAb, Mouse | - | ELISA, PK study | A02262-40 (C) - A02263-40 (D)A02263-40 (C) - A02262-40 (D) |
|
| A02263-40 | Anti-Abatacept Antibody (CT.E8), mAb, Mouse | - | ELISA, PK study |
|
Anti-Certolizumab pegol/Cimzia (Target: TNF alpha)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02268 | MonoRab™ Anti-Certolizumab Antibody (15H11), mAb, Rabbit | Inhibitory | ELISA, PK study | A02268-40 (C) - A02269-40 (D) |
|
| A02269 | MonoRab™ Anti-Certolizumab Antibody (12A3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Ixekizumab/Taltz (Target: IL-17A)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02264-40 | MonoRab™ Anti-Ixekizumab Antibody (19F6), mAb, Rabbit | Inhibitory | ELISA, PK study | A02264-40 (C) - A02265-40 (D) |
|
| A02265-40 | MonoRab™ Anti-Ixekizumab Antibody (29B12), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Ocrelizumab/Ocrevus (Target: CD20)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02258-40 | MonoRab™ Anti-Ocrelizumab Antibody (12G10), mAb, Rabbit | Inhibitory | ELISA, PK study | A02258-40 (C) - A02259-40 (D) |
|
| A02259-40 | MonoRab™ Anti-Ocrelizumab Antibody (15E7), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Teclistamab/Tecvayli (Target: BCMAxCD3)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02253-40 | Anti-Teclistamab Antibody (10H1), mAb, Mouse | Non-inhibitory for CD3 | ELISA, PK study | A02253-40 (C) - A02254-40 (D) |
|
| A02254-40 | Anti-Teclistamab Antibody (36D3), mAb, Mouse | Inhibitory for CD3 | ELISA, PK study |
|
Anti-Vedolizumab/Entyvio (Target: Integrin α₄β₇)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
|
A02324-40
|
MonoRab™ Anti-Vedolizumab Antibody (61A2), mAb, Rabbit | Inhibitory | ELISA, PK study | A02324-40 (C) - A02325-40 (D) |
|
|
A02325-40
|
MonoRab™ Anti-Vedolizumab Antibody (76H8), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
|
A02326-40
|
MonoRab™ Anti-Vedolizumab Antibody (16G2), mAb, Rabbit | Non-inhibitory | ELISA, PK study | - |
|
Anti-Zolbetuximab/IMAB362 (Target: Claudin 18.2)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02260-40 | Anti-Zolbetuximab Antibody (34E11), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02260-40 (C) - A02261-40 (D) |
|
| A02261-40 | Anti-Zolbetuximab Antibody (9C9), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Evolocumab/Repatha (Target: PCSK9)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02293-40 | MonoRab™ Anti-Evolocumab Antibody (39B8), mAb, Rabbit | Inhibitory | ELISA, PK study | A02293-40 (C) - A02294-40 (D) |
|
| A02294-40 | MonoRab™ Anti-Evolocumab Antibody (36A11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Lecanemab/Leqembi (Target: amyloid β)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02270-40 | MonoRab™ Anti-Lecanemab Antibody (44G1), mAb, Rabbit | Inhibitory | ELISA, PK study | A02270-40 (C) - A02271-40 (D) |
|
| A02271-40 | MonoRab™ Anti-Lecanemab Antibody (4F2), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Mosunetuzumab/Cevostamab (Target: CD3)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02290-40 | MonoRab™ Anti-Mosunetuzumab Antibody (4G6), mAb, Rabbit | Inhibitory for CD3 | ELISA, PK study | A02293-40 (C) - A02294-40 (D) |
|
| A02291-40 | MonoRab™ Anti-Mosunetuzumab Antibody (38A10), mAb, Rabbit | Inhibitory for CD3 | ELISA, PK study |
|
|
| A02292-40 | MonoRab™ Anti-Mosunetuzumab Antibody (10D5), mAb, Rabbit | Non-inhibitory for CD3 | ELISA, PK study | / |
|
Anti-OKT3/Muromonab-CD3 (Target: CD3)
| Cat. No. | Product Name | Quantity | Price | Order |
|---|---|---|---|---|
|
A02312
|
MonoRab™ Anti-OKT3/Muromonab Antibody (40D3), mAb, Rabbit |
|
$211.00 40 μg |
|
|
A02313
|
MonoRab™ Anti-OKT3/Muromonab Antibody (9E1), mAb, Rabbit |
|
$211.00 40 μg |
|
Anti-Adalimumab/Humira (Target: TNF alpha)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01954-40 | Anti-Adalimumab Antibody (15C7), mAb, Mouse | Inhibitory | ELISA, PK study | A01954-40 (C) - A01955-40 (D) A01954-40 (C) - A01956-40 (D) |
|
| A01955-40 | Anti-Adalimumab Antibody (3C2), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01956-40 | Anti-Adalimumab Antibody (3C2) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01921-40 | MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit | Inhibitory | ELISA, PK study | A01921-40 (C) - A01922-40 (D) |
|
| A01922-40 | MonoRab™ Anti-Adalimumab Antibody (134D5), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
| A01923-40 | MonoRab™ Anti-Adalimumab Antibody (196F3), mAb, Rabbit | Non-inhibitory | ELISA, PK study | - |
|
| A01886-40 | Anti-Adalimumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Atezolizumab/Tecentriq (Target: PD-L1)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01948-40 | Anti-Atezolizumab Antibody (10G9), mAb, Mouse | Inhibitory | ELISA, PK study |
A01948-40 (C) - A01949-40 (D) A01948-40 (C) - A01950-40 (D) |
|
| A01949-40 | Anti-Atezolizumab Antibody (6B12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01950-40 | Anti-Atezolizumab Antibody (6B12) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01984-40 | MonoRab™ Anti-Atezolizumab Antibody (55D8) mAb, Rabbit | Inhibitory | ELISA, PK study |
A01984-40 (C) - A01985-40 (D) A01984-40 (C) - A01986-40 (D) |
|
| A01985-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
| A01986-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
Anti-Avelumab/Bavencio (Target: PD-L1)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02121-40 | Anti-Avelumab Antibody (12H7), mAb, Mouse | Inhibitory | ELISA, PK study | A02121-40 (C) - A02120-40 (D) |
|
| A02120-40 | Anti-Avelumab Antibody (12G9), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Bevacizumab/Avastin (Target: VEGF-A)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01975-40 | Anti-Bevacizumab Antibody (4H1), mAb, Mouse | - | ELISA, PK study |
A01975-40 (C) - A01976-40 (D) A01975-40 (C) - A01977-40 (D) |
|
| A01976-40 | Anti-Bevacizumab Antibody (6C3), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A01977-40 | Anti-Bevacizumab Antibody (6C3)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A02185-40 | Anti-Bevacizumab Antibody (11C1), mAb, Mouse | Inhibitory | ELISA, PK study | A02185-40 (C) - A01962-40 (D) A02185-40 (C) - A01896-40 (D) |
|
| A01895-40 | MonoRab™ Anti-Bevacizumab Antibody (30E1), mAb, Rabbit | Non-inhibitory | ELISA, PK study | A01895-40 (C) - A01962-40 (D) A01895-40 (C) - A01896-40 (D) |
|
| A01962-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
| A01896-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
| A01887-40 | Anti-Bevacizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Cetuximab/Erbitux (Target: EGF Receptor)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01939-40 | Anti-Cetuximab Antibody (20H1), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01939-40 (C) - A01938-40 (D) |
|
| A01938-40 | Anti-Cetuximab Antibody (18D5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A01991-40 | MonoRab™ Anti-Cetuximab Antibody (69H10), mAb, Rabbit | Inhibitory | ELISA, PK study | A01991-40 (C) - A01992-40 (D) |
|
| A01992-40 | MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Daratumumab/Darzalex (Target: CD38)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01996-40 | Anti-Daratumumab Antibody (11F2), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01996-40 (C) - A01997-40 (D) |
|
| A01997-40 | Anti-Daratumumab Antibody (6A3), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A01998-40 | Anti-Daratumumab Antibody (9A6), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
| A02009-40 | MonoRab™ Anti-Daratumumab(139B10), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
Anti-Denosumab/Prolia (Target: RANK Ligand)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02229-40 | Anti-Denosumab Antibody (3B1), mAb, Mouse | Inhibitory | ELISA, PK study | A02229-40 (C) - A02230-40 (D) |
|
| A02230-40 | Anti-Denosumab Antibody (16F2), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A02101-40 | Anti-Denosumab Antibody (2H7), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02101-40 (C) - A02102-40 (D) |
|
| A02102-40 | Anti-Denosumab Antibody (9A10), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Dupilumab/Dupixent (Target: IL-4Rα)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02098-40 | Anti-Dupilumab Antibody (6C9), mAb, Mouse | Inhibitory | ELISA, PK study | A02098-40 (C) - A02097-40 (D) |
|
| A02097-40 | Anti-Dupilumab Antibody (2D5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Durvalumab/Imfinzi (Target: CD274)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02031-40 | Anti-Durvalumab Antibody (15D6), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
Anti-Eculizumab/Soliris (Target: Complement protein C5)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02115-40 | Anti-Eculizumab Antibody (4F6), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02115-40 (C) - A02116-40 (D) |
|
| A02116-40 | Anti-Eculizumab Antibody(13F5), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Etanercept/Enbrel (Target: TNF alpha)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02114-40 | Anti-Etanercept Antibody (4H5), mAb, Mouse | Inhibitory | ELISA, PK study | A02114-40 (C) - A02113-40 (D) |
|
| A02113-40 | Anti-Etanercept Antibody (4H1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
Anti-Golimumab/Simponi (Target: TNF alpha)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02093-40 | Anti-Golimumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Infliximab/Remicade (Target: TNF alpha)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02040-40 | Anti-Infliximab Antibody (27A4) , mAb, Mouse | Non-inhibitory | ELISA, PK study | A02040-40 (C) - A02041-40 (D) |
|
| A02041-40 | Anti-Infliximab Antibody (23H5) , mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A02061-40 | Anti-Infliximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Ipilimumab/Yervoy (Target: CTLA-4)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01859-40 | Anti-Ipilimumab Antibody(26B6H7D9), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01859-40 (C) - A01961-40 (D) A01859-40 (C) - A01858-40 (D) |
|
| A01961-40 | Anti-Ipilimumab Antibody (4H6), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01858-40 | Anti-Ipilimumab Antibody (4H6)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
Anti-Nivolumab/Opdivo (Target: PD-1)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01847-40 | Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01847-40 (C) - A01965-40 (D) A01847-40 (C) - A01848-40 (D) |
|
| A01965-40 | Anti-Nivolumab Antibody (6G5), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01848-40 | Anti-Nivolumab Antibody(6G5)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01987-40 | MonoRab™ Anti-Nivolumab Antibody (33H4), mAb, Rabbit | Inhibitory | ELISA, PK study |
A01987-40 (C) - A01988-40 (D) A01987-40 (C) - A01989-40 (D) |
|
| A01988-40 | MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
| A01989-40 | MonoRab™ Anti-Nivolumab Antibody (40F11)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
| A01990-40 | MonoRab™ Anti-Nivolumab Antibody (47F6), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
| A01931-40 | Anti-Nivolumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Obinutuzumab/Gazyva (Target: CD20)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01945-40 | Anti-Obinutuzumab Antibody (18H8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01945-40 (C) - A01946-40 (D) A01945-40 (C) - A01947-40 (D) |
|
| A01946-40 | Anti-Obinutuzumab Antibody (16B7), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01947-40 | Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01966-40 | MonoRab™ Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01966-40 (C) - A01967-40 (D) A01966-40 (C) - A01968-40 (D) |
|
| A01967-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
|
|
| A01968-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
| A01933-40 | Anti-Obinutuzumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Omalizumab/Xolair (Target: Human IgE)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02095-40 | Anti-Omalizumab Antibody (10G3), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02095-40 (C) - A02094-40 (D) |
|
| A02094-40 | Anti-Omalizumab Antibody (15B12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A02096-40 | Anti-Omalizumab Antibody (7G11), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
Anti-Palivizumab/Synagis (Target: RSV F)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02112-40 | Anti-Palivizumab Antibody (7B3), mAb, Mouse | Inhibitory | ELISA, PK study | A02112-40 (C) - A02111-40 (D) |
|
| A02111-40 | Anti-Palivizumab Antibody (2F12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A02064-40 | Anti-Palivizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Panitumumab/Vectibix (Target: EGF Receptor)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02100-40 | Anti-Panitumumab Antibody (9G12), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02100-40 (C) - A02099-40 (D) |
|
| A02099-40 | Anti-Panitumumab Antibody (2E7), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A02063-40 | Anti-Panitumumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Pembrolizumab/Keytruda (Target: PD-1)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01844-40 | Anti-Pembrolizumab Antibody(1D6E10), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
|
| A01845-40 | Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse | - | ELISA, PK study | - |
|
| A02008-40 | MonoRab™ Anti-Pembrolizumab Antibody (94B9), mAb, Rabbit | Inhibitory | ELISA, PK study | A02008-40 (C) - A02007-40 (D) |
|
| A02007-40 | MonoRab™ Anti-Pembrolizumab Antibody (47E5), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
|
| A01960-40 | MonoRab™ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit | Inhibitory | ELISA, PK study | - |
|
| A01853-40 | MonoRab™ Anti-Pembrolizumab Antibody(90G12)[Biotin], mAb, Rabbit | - | ELISA, PK study | - |
|
| A01846-40 | Anti-Pembrolizumab Antibody, pAb, Rabbit | - | ELISA,Immunogenicity assay | - |
|
Anti-Pembrolizumab/Keytruda PK ELISA Kit
| Cat. No. | Product Name | Application | Order |
|---|---|---|---|
| L00968 | Pembrolizumab Pharmacokinetic ELISA Kit | GenScript’s Pembrolizumab Pharmacokinetic ELISA Kit is designed to quantify Pembrolizumab in serum and plasma with high specificity and sensitivity. The precision, accuracy, dilution linearity, specificity, selectivity, stability and hook effect of the kit were evaluated and validated according to ICH M10 and the FDA bioanalytical method validation guidance for industry and are all acceptable. The kit can be used for the quantification of whole Pembrolizumab and its biosimilars during drug research and development, and also for the detection of single-stranded variable fragments (scFv) of Pembrolizumab. |
|
Anti-Pertuzumab/Perjeta (Target: HER2)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02150-40 | Anti-Pertuzumab Antibody (1A3), mAb, Mouse | Inhibitory | ELISA, PK study | A02150-40 (C) - A02151-40 (D) |
|
| A02151-40 | Anti-Pertuzumab Antibody (11H4), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A02208-40 | Anti-Pertuzumab Antibody (7H7), mAb, Mouse | Inhibitory | ELISA, PK study | A02150-40 (C) - A02208-40 (D) |
|
| A02209-40 | Anti-Pertuzumab Antibody (16E2), mAb, Mouse | Inhibitory | ELISA, PK study | A02209-40 (C) - A02151-40 (D) |
|
| A02220-40 | Anti-Pertuzumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Ranibizumab/Lucentis (Target: VEGF-A)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02035-40 | Anti-Ranibizumab Antibody (6C3), mAb, Mouse | Inhibitory | ELISA, PK study | A02035-40 (C) - A02036-40 (D) |
|
| A02036-40 | Anti-Ranibizumab Antibody (10D12), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A02037-40 | Anti-Ranibizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Risankizumab/Skyrizi (Target: IL-23)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
|
A02321-40
|
MonoRab™ Anti-Risankizumab Antibody (3A11), mAb, Rabbit | Inhibitory | ELISA, PK study | A02321-40 (C) - A02322-40 (D) |
|
|
A02322-40
|
MonoRab™ Anti-Risankizumab Antibody (32A12), mAb, Rabbit | Inhibitory | ELISA, PK study |
|
Anti-Rituximab/Rituxan (Target: CD20)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01969-40 | Anti-Rituximab Antibody (6C1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01969-40 (C) - A01970-40 (D) A01969-40 (C) - A01971-40 (D) |
|
| A01970-40 | Anti-Rituximab Antibody (17B6), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A01971-40 | Anti-Rituximab Antibody (17B6)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01942-40 | MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01942-40 (C) - A01943-40 (D) A01942-40 (C) - A01944-40 (D) |
|
| A01943-40 | MonoRab™ Anti-Rituximab Antibody (194D7), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
|
|
| A01944-40 | MonoRab™ Anti-Rituximab Antibody (194D7)[Biotin], mAb, Rabbit | - | ELISA, PK study |
|
|
| A01918-40 | Anti-Rituximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
|
Anti-Sarilumab/Kevzara (Target: IL-6 Receptor)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02042-40 | Anti-Sarilumab Antibody (26B10) , mAb, Mouse | Inhibitory | ELISA, PK study | A02042-40 (C) - A02043-40 (D) |
|
| A02043-40 | Anti-Sarilumab Antibody (23H12) , mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A02044-40 | Anti-Sarilumab Antibody (20F5), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
|
| A02122-40 | Anti-Sarilumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Secukinumab/Cosentyx (Target: IL-17A)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02152-40 | Anti-Secukinumab Antibody (22G7), mAb, Mouse | Inhibitory | ELISA, PK study | A02152-40 (C) - A02153-40 (D) |
|
| A02153-40 | Anti-Secukinumab Antibody (23E11), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Tocilizumab/Actemra (Target: IL-6 Receptor)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A01978-40 | Anti-Tocilizumab Antibody (14B10), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01978-40 (C) - A01979-40 (D) A01978-40 (C) - A01980-40 (D) |
|
| A01979-40 | Anti-Tocilizumab Antibody (6C10), mAb, Mouse | Inhibitory | ELISA, PK study |
|
|
| A01980-40 | Anti-Tocilizumab Antibody (6C10)[Biotin], mAb, Mouse | - | ELISA, PK study |
|
|
| A01932-40 | Anti-Tocilizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
Anti-Trastuzumab/Herceptin (Target: HER2)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02032-40 | Anti-Trastuzumab Antibody (11C4), mAb, Mouse | Inhibitory | ELISA, PK study | A02032-40 (C) - A02033-40 (D) |
|
| A02033-40 | Anti-Trastuzumab Antibody (15H2), mAb, Mouse | Inhibitory | ELISA, PK study |
|
Anti-Ustekinumab/Stelara (Target: IL-12 & IL-23)
| Cat. No. | Product Name | Binding Type | Recommend Applications | Recommended Pairs (Capture-Detection) | Order |
|---|---|---|---|---|---|
| A02118-40 | Anti-Ustekinumab Antibody (9A5), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02118-40 (C) - A02117-40 (D) |
|
| A02117-40 | Anti-Ustekinumab Antibody (5F9), mAb, Mouse | Non-inhibitory | ELISA, PK study |
|
|
| A02119-40 | Anti-Ustekinumab Antibody (11E3), mAb, Mouse | Inhibitory | ELISA, PK study | - |
|
| A02123-40 | Anti-Ustekinumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
|
GenScript's anti-idiotypic antibodies are suitable for a variety of applications in PK studies.
GenScript offers two different types of monoclonal anti-idiotypic antibodies for PK studies, detecting free drug and total drug levels.
| Type | Blocking | Non-blocking |
|---|---|---|
| Diagram |  |
 |
| Feature | Paratope specific | Paratope nonspecific |
| Antigen binding | Inhibition | Non-inhibition |
| Application | Detection of free antibody drugs | Detection of total antibody drug amount (free and bound) |
GenScript's anti-idiotypic antibodies are suitable for a variety of applications in ADA research
BLI (Biolayer interferometry) binding affinity measurements of MonoRab™ Anti-Evolocumab Antibody (39B8), mAb, Rabbit (GenScript, A02293) to Evolocumab.Evolocumab captured on HFC (Anti-Human IgG Fc) Probes can bind MonoRab™ Anti-Evolocumab Antibody (39B8), mAb, Rabbit with a dissociation constant (KD) of less than 1 pM.
Specificity analysis of the detection of Ocrelizumab. Ocrelizumab samples at 5 concentrations were spiked with 10 μg/mL of Rituximab. The test result demonstrated that the high concentration of Rituximab did not interfere with the detection of Ocrelizumab. In this ELISA assay, MonoRab™ Anti-Ocrelizumab Antibody (12G10), mAb, Rabbit (GenScript, A02258) was coated at a concentration of 1 μg/mL, and MonoRab™ Anti-Ocrelizumab Antibody (15E7), mAb, Rabbit (GenScript, A02259) conjugated with Biotin was used as a detection antibody at a concentration of 0.5 μg/mL.
ELISA binding of Anti-Trastuzumab Antibody (11C4), mAb, Mouse (GenScript, A02032-40) with Trastuzumab and Pertuzumab. It shows the antibody does not recognize Pertuzumab. Coating antigen: Pertuzumab 1 µg/ml. Trastuzumab 1 µg/ml. Anti-Trastuzumab Antibody (11C4), mAb, Mouse (GenScript, A02032-40) dilution start from 1,000 ng/ml.
MRD Analysis of the Detection of Lecanemab in Biological Matrix. The MRD is the minimum dilution necessary for the detection of Lecanemab in biological matrix with least interference. Serum samples from cynomolgus monkey were serially diluted to determine the MRD of this assay, and the test result suggested that MRD was as 1:10. In this ELISA assay, MonoRab™ Anti-Lecanemab Antibody (44G1), mAb, Rabbit (GenScript, A02270) was coated at a concentration of 1 μg/ml, and MonoRab™ Anti-Lecanemab Antibody (4F2), mAb, Rabbit (GenScript, A02271) conjugated with Biotin was used as a detection antibody at a concentration of 0.5 μg/mL.
Standard Curve of Lecanemab Sandwich ELISA by Anti-Lecanemab
idiotype antibody 44G1 and 4F2.
In this Sandwich ELISA assay, MonoRab™ Anti-Lecanemab Antibody (44G1), mAb, Rabbit
(GenScript, A02270) was coated at a concentration of 1 μg/ml, and MonoRab™
Anti-Lecanemab Antibody (4F2), mAb, Rabbit (GenScript, A02271) conjugated with
Biotin was used as a detection antibody at a concentration of 0.5 μg/mL. GenScript
can provide customized conjugation service for this product per customer's
request.
In this assay, a four-parameter logistic curve fitting program was used to create a
standard curve with the R-Square equal to 0.99971. The typicaldynamic range of the
assay is 0.31 - 20 ng/mL and its detection limit is 0.31 ng/mL.
Standard curve of the detection of Abatacept by Anti-Abatacept Antibody (CT.E8) and anti-human IgG Fc antibody. In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was coated at a concentration of 1 μg/ml, and Mouse Anti-Human IgG Fc Antibody (50B4A9)[HRP], mAb (GenScript, A01854) was used as a detection antibody at a dilution of 1:2000. In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 4.69-300 ng/mL and its sensitivity of detecting Abatacept is up to 4.69 ng/mL.
Standard curve and specificity analysis of the detection of Certolizumab pegol by Anti-Certolizumab Antibody (12A3) and anti-PEG antibody. In the ELISA assay shown in this chart, THE™ PEG Antibody, mAb, Mouse (GenScript, A01795) was coated at a concentration of 2 μg/mL, and MonoRab™ Anti-Certolizumab Antibody (12A3), mAb, Rabbit (GenScript, A02269) conjugated with Biotin was used as a detection antibody at a concentration of 0.5 μg/mL. In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.999. The typicaldynamic range of the assay is 0.55-400 ng/mL and its sensitivity of detecting Certolizumab pegol is up to 0.55 ng/mL.
Anti-Zolbetuximab Antibody (34E11) or (9C9) inhibits the binding of Zolbetuximab to Claudin18.2 (CLDN18.2). Anti-Zolbetuximab Antibody (34E11), mAb, Mouse (GenScript, A02260) exhibited non-inhibitory properties, whereas Anti-Zolbetuximab Antibody (9C9), mAb, Mouse (GenScript, A02261) demonstrated significant inhibitory properties with an IC50 value of 0.44 µg/mL.
Standard curve of the detection of Trastuzumab deruxtecan (DS-8201) by Anti-Trastuzumab Antibody (15H2) and DXd Antibody (39F4) In this ELISA assay, Anti-Trastuzumab Antibody (11C4), mAb, Mouse (GenScript, A02032) was coated at a concentration of 2 μg/mL, and DXd Antibody (39F4), mAb, Mouse (GenScript, A02217) conjugated with HRP was used as a detection antibody at a concentration of 0.22 μg/mL. In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 1.56 - 100 ng/mL and its sensitivity of detecting Trastuzumab deruxtecan (DS-8201) is up to 1.56 ng/mL.
Show More
Close
